Mizral-F 5 Tablet ER
Marketer
Ryon Pharma
Salt Composition
Propranolol (40mg) + Flunarizine (5mg)
Overview Mizral-F 5 Tablet ER
Combiflex-M 5 Extended-Release tablets combine two medications to prevent migraine episodes. This medication isn't for treating acute migraine attacks. Take Combiflex-M 5 ER on an empty stomach, consistently at the same time each day, ideally at night. Dosage and frequency depend on your individual needs; your physician will determine the appropriate regimen to manage your symptoms. Continue using this medication for the prescribed duration. Lifestyle adjustments, such as stress reduction, smoking cessation, and limiting processed foods, can enhance its effectiveness. Common side effects may include weight increase, bradycardia, fatigue, depressive symptoms, somnolence, and cold extremities. Drowsiness is possible; avoid driving or activities requiring alertness, and rise slowly from a seated position. This medication can mask hypoglycemia symptoms, so regular blood glucose and blood pressure monitoring are essential. Inform your doctor of any liver or kidney disease, depression, pregnancy, breastfeeding, or other medications you're using, as drug interactions can reduce efficacy or alter the medication's effects.
Primary Ingredients of Mizral-F 5 Tablet ER
No text was provided. Please provide the text you would like me to rephrase.
Uses of Mizral-F 5 Tablet ER
Migraine Prevention Strategies
Major Benefits of Mizral-F 5 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mizral-F 5 Tablet ER on an empty stomach.
Common Side effects of Mizral-F 5 Tablet ER:
- Weight gain
- Slow heart rate
- Tiredness
- Depression
- Drowsiness
- Abnormal dreams
- Cold extremities
How to use Mizral-F 5 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Mizral-F 5 Tablet ER should be administered on an empty stomach.
How Mizral-F 5 Tablet ER works:
Mizral-F 5 Extended-Release tablets combine propranolol, a beta-blocker, and flunarizine, a calcium channel blocker, to prevent migraine headaches. This dual action stabilizes overactive nerve cells, raising the threshold for migraine onset. The medication further counters cortical spreading depression—electrical brainwave activity triggering pain and inflammation—thus mitigating migraine attacks.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mizral-F 5 Tablet ER and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Mizral-F 5 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mizral-F 5 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Mizral-F 5 Tablet ER, which can induce side effects such as visual disturbances, hallucinations, fatigue, cognitive impairment, dizziness, or drowsiness.
KidneySAFE IF PRESCRIBED
Extended-release Mizral-F 5mg tablets are likely safe for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary, but physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Mizral-F 5 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is recommended. Routine blood pressure checks are advised to guide dosage adjustments.
What if you forget to take Mizral-F 5 Tablet ER :
Should you forget to take a Mizral-F 5 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mizral-F 5 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently